JAMES CROSS

Allopathic & Osteopathic Physicians|Surgery PLANO, TX NPI 1013950625

General Payments — all program years on this page

$4,809.20

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 72
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $811.37 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $811.3720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $532.569
2019 $1,389.089
2021 $292.139
2022 $574.987
2023 $1,209.0818
2024 $811.3720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1120094511 Kerecis Limited $42.07 01/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120112232 Kerecis Limited $134.72 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126197853 Avita Medical Americas, Llc $44.43 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574206 Vericel Corporation $24.96 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574208 Vericel Corporation $36.19 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574210 Vericel Corporation $24.45 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574212 Vericel Corporation $23.59 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574214 Vericel Corporation $24.32 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574216 Vericel Corporation $14.00 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574218 Vericel Corporation $18.61 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574220 Vericel Corporation $17.50 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574222 Vericel Corporation $38.83 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574224 Vericel Corporation $24.05 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128574226 Vericel Corporation $19.10 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140100962 Integra LifeSciences Corporation $31.11 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140100967 Integra LifeSciences Corporation $74.15 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142078430 Teleflex LLC $31.52 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148176424 PolyNovo North America LLC $56.25 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148176426 PolyNovo North America LLC $108.04 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153024614 LifeNet Health $23.48 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.